|Mr. Michael W. Yurkowsky||CEO & Director||180k||N/A||1972|
|Mr. Jeremy D. Daniel||Chief Financial Officer||200k||N/A||1976|
|Dr. Tanya Rhodes Ph.D.||Chief Scientific Officer||252k||N/A||1961|
|Mr. Jeffery Wright CPA, CPA||Controller & Principal Accounting Officer||N/A||N/A||1983|
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
H-CYTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.